Rankings
▼
Calendar
VCYT Q4 2016 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena
VCYT
Veracyte, Inc.
$3B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$18M
Gross Profit
$12M
64.3% margin
Operating Income
-$4M
-20.1% margin
Net Income
-$4M
-24.1% margin
EPS (Diluted)
$-0.14
QoQ Revenue Growth
-1.9%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$5M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$101M
Total Liabilities
$41M
Stockholders' Equity
$60M
Cash & Equivalents
$59M
← FY 2016
All Quarters
Q1 2017 →